Inmune Bio Inc. (INMB)
NASDAQ · Healthcare
Inmune Bio Inc. Total Liabilities 2017–2025
Inmune Bio Inc. annual total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Inmune Bio Inc. total liabilities as of December 31, 2025: 8.8M, a 18.25% increase year-over-year.
- Inmune Bio Inc. total liabilities for 2025 were 8.8M, a 18.25% increase from 2024.
- Inmune Bio Inc. total liabilities for 2024 were 7.5M, a 60.42% decrease from 2023.
- Inmune Bio Inc. total liabilities for 2023 were 18.9M, a 13.04% decrease from 2022.
- Inmune Bio Inc. total liabilities for 2022 were 21.7M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Inmune Bio Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $9 |
| 2024 | $7 |
| 2023 | $19 |
| 2022 | $22 |
| 2021 | $20 |
| 2020 | $2 |
| 2018 | $1 |
| 2017 | $0 |
Inmune Bio Inc. Total Liabilities — FAQ
Inmune Bio Inc. (INMB) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INMB's total liabilities history?
The chart and table above show Inmune Bio Inc.'s total liabilities by year and by quarter, including the growth rate.